GARP Is Regulated by miRNAs and Controls Latent TGF-β1 Production by Human Regulatory T Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Gauthy, Emilie ^a   Cuende, Julia ^a   Stockis, Julie ^a   Huygens, Caroline ^a   Lethé, Bernard ^b   Collet, Jean François ^a   Bommer, Guido ^a   Coulie, Pierre G ^a   Lucas, Sophie ^a  

^a DE DUVE INSTITUTE   (Belgium)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIDE; MEMBRANE PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 142 3P; MICRORNA 181A; MICRORNA 181B; MICRORNA 181C; MICRORNA 185; PROTEIN GARP; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; WESTERN BLOTTING;

BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; MEMBRANE PROTEINS; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84884790901     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076186     Document Type: Article

References (50)

1. Josefowicz SZ, Lu LF, Rudensky AY, (2012) Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30: 531-564. doi:10.1146/annurev.immunol.25.022106.141623. PubMed: 22224781.
2. Klages K, Mayer CT, Lahl K, Loddenkemper C, Teng MW, et al. (2010) Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma. Cancer Res 70: 7788-7799. doi:10.1158/0008-5472.CAN-10-1736. PubMed: 20924102.
3. Li X, Kostareli E, Suffner J, Garbi N, Hämmerling GJ, (2010) Efficient Treg depletion induces T-cell infiltration and rejection of large tumors. Eur J Immunol 40: 3325-3335. doi:10.1002/eji.201041093. PubMed: 21072887.
4. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, et al. (1999) Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59: 3128-3133. PubMed: 10397255.
5. Shimizu J, Yamazaki S, Sakaguchi S, (1999) Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 163: 5211-5218. PubMed: 10553041.
6. Turk MJ, Guevara-Patiño JA, Rizzuto GA, Engelhorn ME, Sakaguchi S, et al. (2004) Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med 200: 771-782. doi:10.1084/jem.20041130. PubMed: 15381730.
7. Sakaguchi S, Miyara M, Costantino CM, Hafler DA, (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490-500. doi:10.1038/nri2785. PubMed: 20559327.
8. Wang HY, Wang RF, (2007) Regulatory T cells and cancer. Curr Opin Immunol 19: 217-223. doi:10.1016/j.coi.2007.02.004. PubMed: 17306521.
9. Stockis J, Fink W, François V, Connerotte T, de Smet C, et al. (2009) Comparison of stable human Treg and Th clones by transcriptional profiling. Eur J Immunol 39: 869-882. doi:10.1002/eji.200838807. PubMed: 19224638.
10. Baron U, Floess S, Wieczorek G, Baumann K, Grützkau A, et al. (2007) DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 37: 2378-2389. doi:10.1002/eji.200737594. PubMed: 17694575.
11. de Vries IJ, Castelli C, Huygens C, Jacobs JF, Stockis J, et al. (2011) Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents. Clin Cancer Res 17: 841-848. doi:10.1158/1078-0432.CCR-10-2227. PubMed: 21177412.
12. Wieczorek G, Asemissen A, Model F, Turbachova I, Floess S, et al. (2009) Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 69: 599-608. doi:10.1158/0008-5472.CAN-08-2361. PubMed: 19147574.
13. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, et al. (1992) Targeted disruption of the mouse transforming growth factor-[β]1 gene results in multifocal inflammatory disease. Nature 359: 693-699. doi:10.1038/359693a0. PubMed: 1436033.
14. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA, (2006) Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24: 99-146. doi:10.1146/annurev.immunol.24.021605.090737. PubMed: 16551245.
15. ten Dijke P, Arthur HM, (2007) Extracellular control of TGFβ signalling in vascular development and disease. Nat Rev Mol Cell Biol 8: 857-869. doi:10.1038/nrm2262. PubMed: 17895899.
16. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, et al. (1986) Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J Immunol 137: 3855-3860. PubMed: 2878044.
17. Stockis J, Colau D, Coulie PG, Lucas S, (2009) Membrane protein GARP is a receptor for latent TGF-β on the surface of activated human Treg. Eur J Immunol 39: 3315-3322. doi:10.1002/eji.200939684. PubMed: 19750484.
18. Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, et al. (2004) TGF-β 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 172: 834-842. PubMed: 14707053.
19. Nakamura K, Kitani A, Strober W, (2001) Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor β. J Exp Med 194: 629-644. doi:10.1084/jem.194.5.629. PubMed: 11535631.
20. Tran DQ, Andersson J, Wang R, Ramsey H, Unutmaz D, et al. (2009) GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci U S A 106: 13445-13450. doi:10.1073/pnas.0901944106. PubMed: 19651619.
21. Wang R, Wan Q, Kozhaya L, Fujii H, Unutmaz D, (2008) Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLOS ONE 3: e2705. doi:10.1371/journal.pone.0002705. PubMed: 18628982.
22. Probst-Kepper M, Geffers R, Kröger A, Viegas N, Erck C, et al. (2009) GARP: a key receptor controlling FOXP3 in human regulatory T cells. J Cell Mol Med 13: 3343-3357. doi:10.1111/j.1582-4934.2009.00782.x. PubMed: 19453521.
23. Wang R, Zhu J, Dong X, Shi M, Lu C, et al. (2012) GARP regulates the bioavailability and activation of TGFβ. Mol Cell Biol 23: 1129-1139. doi:10.1091/mbc.E11-12-1018.
24. Shi M, Zhu J, Wang R, Chen X, Mi L, et al. (2011) Latent TGF-β structure and activation. Nature 474: 343-349. doi:10.1038/nature10152. PubMed: 21677751.
25. Todorovic V, Rifkin DB, (2012) LTBPs, more than just an escort service. J Cell Biochem 113: 410-418. doi:10.1002/jcb.23385. PubMed: 22223425.
26. Rossi RL, Rossetti G, Wenandy L, Curti S, Ripamonti A, et al. (2011) Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat Immunol 12: 796-803. doi:10.1038/ni.2057. PubMed: 21706005.
27. Dubois CM, Blanchette F, Laprise MH, Leduc R, Grondin F, et al. (2001) Evidence that furin is an authentic transforming growth factor-β1-converting enzyme. Am J Pathol 158: 305-316. doi:10.1016/S0002-9440(10)63970-3. PubMed: 11141505.
28. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R, (1995) Processing of transforming growth factor β 1 precursor by human furin convertase. J Biol Chem 270: 10618-10624. doi:10.1074/jbc.270.18.10618. PubMed: 7737999.
29. Pesu M, Watford WT, Wei L, Xu L, Fuss I, et al. (2008) T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature 455: 246-250. doi:10.1038/nature07210. PubMed: 18701887.
30. Miyazono K, Olofsson A, Colosetti P, Heldin CH, (1991) A role of the latent TGF-β 1-binding protein in the assembly and secretion of TGF-β 1. EMBO J 10: 1091-1101. PubMed: 2022183.
31. Rifkin DB, (2005) Latent transforming growth factor-β (TGF-β) binding proteins: orchestrators of TGF-β availability. J Biol Chem 280: 7409-7412. PubMed: 15611103.
32. Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, et al. (2005) Aberrant T cell differentiation in the absence of Dicer. J Exp Med 202: 261-269. doi:10.1084/jem.20050678. PubMed: 16009718.
33. Cobb BS, Nesterova TB, Thompson E, Hertweck A, O'Connor E, et al. (2005) T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 201: 1367-1373. doi:10.1084/jem.20050572. PubMed: 15867090.
34. Chong MM, Rasmussen JP, Rudensky AY, Littman DR, (2008) The RNAse III enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med 205: 2005-2017. doi:10.1084/jem.20081219. PubMed: 18725527.
35. Liston A, Lu LF, O'Carroll D, Tarakhovsky A, Rudensky AY, (2008) Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 205: 1993-2004. doi:10.1084/jem.20081062. PubMed: 18725526.
36. Zhou X, Jeker LT, Fife BT, Zhu S, Anderson MS, et al. (2008) Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 205: 1983-1991. doi:10.1084/jem.20080707. PubMed: 18725525.
37. Cobb BS, Hertweck A, Smith J, O'Connor E, Graf D, et al. (2006) A role for Dicer in immune regulation. J Exp Med 203: 2519-2527. doi:10.1084/jem.20061692. PubMed: 17060477.
38. Fayyad-Kazan H, Rouas R, Fayyad-Kazan M, Badran R, El Zein N, et al. (2012) MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function. J Biol Chem 287: 9910-9922. doi:10.1074/jbc.M111.337154. PubMed: 22294691.
39. Jeker LT, Zhou X, Gershberg K, de Kouchkovsky D, Morar MM, et al. (2012) MicroRNA 10a marks regulatory T cells. PLOS ONE 7: e36684. doi:10.1371/journal.pone.0036684. PubMed: 22629323.
40. Rouas R, Fayyad-Kazan H, El Zein N, Lewalle P, Rothé F, et al. (2009) Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol 39: 1608-1618. doi:10.1002/eji.200838509. PubMed: 19408243.
41. O'Connell RM, Rao DS, Baltimore D, (2012) microRNA regulation of inflammatory responses. Annu Rev Immunol 30: 295-312. doi:10.1146/annurev-immunol-020711-075013. PubMed: 22224773.
42. Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, et al. (2009) Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30: 80-91. doi:10.1016/j.immuni.2008.11.010. PubMed: 19144316.
43. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, et al. (2010) Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142: 914-929. doi:10.1016/j.cell.2010.08.012. PubMed: 20850013.
44. Huang B, Zhao J, Lei Z, Shen S, Li D, et al. (2009) miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep 10: 180-185. doi:10.1038/embor.2008.224. PubMed: 19098714.
45. Zhou Q, Haupt S, Prots I, Thümmler K, Kremmer E, et al. (2013) miR-142-3p Is Involved in CD25+ CD4 T Cell Proliferation by Targeting the Expression of Glycoprotein A Repetitions Predominant. J Immunol, 190: 6579-88. PubMed: 23650616.
46. Zhao J, Cao Y, Lei Z, Yang Z, Zhang B, et al. (2010) Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels. Cancer Res 70: 4850-4858. doi:10.1158/1538-7445.AM10-4850. PubMed: 20501849.
47. Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, et al. (2007) Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 204: 1303-1310. doi:10.1084/jem.20062129. PubMed: 17502663.
48. Klein M, Vaeth M, Scheel T, Grabbe S, Baumgrass R, et al. (2012) Repression of cyclic adenosine monophosphate upregulation disarms and expands human regulatory T cells. J Immunol 188: 1091-1097. doi:10.4049/jimmunol.1102045. PubMed: 22190184.
49. Brunner AM, Marquardt H, Malacko AR, Lioubin MN, Purchio AF, (1989) Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor β 1 precursor. Expression and characterization of mutant proteins. J Biol Chem 264: 13660-13664. PubMed: 2474534.
50. Zuker M, (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31: 3406-3415. doi:10.1093/nar/gkg595. PubMed: 12824337.